Aarti Pharmalabs inaugurates phase 1 of greenfield manufacturing facility
Phase 1 has a total reactor capacity of 440 kL with 63 reactors
Phase 1 has a total reactor capacity of 440 kL with 63 reactors
The 27 greenfield labs across the country ensure timely and accurate reporting
The plant will have installed production capacity of 3,120 MT/month
This is Senores' second API manufacturing facility adding significantly to the existing API manufacturing capabilities.
PLI scheme envisages manufacturing of 41 Bulk Drugs with a total outlay of Rs. 6,940 cr. during the tenure of the scheme from 2020-21 to 2029-30
The estimated capex is to the tune of Rs. 140 crore to be funded through debt and internal accrual
The greenfield facility in Madhya Pradesh expected to create up to 500 direct jobs, in addition to generating indirect employment opportunities
Medanta expanded its bed capacity by 20% during the year
TheraNym will set up a greenfield large-scale mammalian drug substance manufacturing facility
Subscribe To Our Newsletter & Stay Updated